Academic awarded £1,370 for Atrial Fibrillation Screening Study

Faculty of Science fund devices for a new study in Medway and Kent

3rd April 2017

Faculty of Sciences Research Funding.

Emma Veale was awarded £1370 from the Faculty of Science to fund devices for an Atrial Fibrillation Screening study in Medway and Kent.

In September 2017, to coincide with the flu vaccination season, clinical pharmacists based within general practices, in Medway and Kent, will embark on a Atrial Fibrillation screening programme of the over 65’s. This project is led by academics at the Medway School of Pharmacy in collaboration with cardiologists from the Medway Maritime Hospital, GPs and clinical pharmacists from local practices. Atrial fibrillation (AF) is an age-related condition that affects >6% of people aged 65 or over. Left untreated, it is associated with significant cardiovascular complications and a 5-fold increased risk of stroke, which can cause severe disability or death. AF is characterised by an irregular pulse that can be detected by a simple pulse check, followed by a confirmatory electrocardiogram (ECG). Clinical pharmacists will be trained to measure a pulse and a take a two-lead ECG, using the AliveCor® Kardia Mobile single-lead handheld ECG.

AliveCor® Kardia Mobile single-lead handheld ECG (Photo used by permission).
The aim of the project is to establish a National Screening programme for AF within a primary care setting, run by clinical pharmacists.

The Sciences Faculty Research Fund 2017, has very generously funded three of the AliveCor® Kardia Mobile devices and associated android recording device, for testing in clinics.

 

Tel: +44 (0) 1634 202935
Fax: +44 (0) 1634 883927

Copyright © Medway School of Pharmacy
Last Updated 03/04/2017